Limb Splinting for Intravenous Cannulae in Neonates and Its Effects on Life Span of Intravenous Cannulae
Launched by RAWALPINDI MEDICAL COLLEGE · Sep 25, 2024
Trial Information
Current as of April 02, 2025
Completed
Keywords
ClinConnect Summary
This randomized controlled trial aims to investigate the impact of limb splinting on the lifespan of intravenous (IV) cannulae in neonates. The study is motivated by the need to enhance the efficacy and safety of peripheral IV cannulation in neonates, who frequently require intravenous access for the administration of medications and fluids during hospitalization. Peripheral IV cannulation, although common, is associated with a limited dwell time and various complications, including extravasation, occlusion, and leakage, which can lead to multiple cannulations and increased discomfort for n...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All neonates with intravenous cannulae
- Exclusion Criteria:
- • All neonates in neonatal ICU
- • All neonates with central venous line in place
- • All neonates that are on ventilatory support
Trial Officials
Ali Raza Chaudhry, MBBS, MS
Study Director
Rawalpindi Medical College
Mudassar Fiaz Gondal, MBBS, MS
Study Chair
Rawalpindi Medical College
hasnain Aslam, MBBS
Principal Investigator
Rawalpindi Medical College
About Rawalpindi Medical College
Rawalpindi Medical College is a prestigious medical institution dedicated to advancing healthcare through rigorous clinical research and education. With a commitment to improving patient outcomes, the college actively sponsors clinical trials that explore innovative therapeutic approaches and enhance medical knowledge across various disciplines. Its team of experienced researchers and clinicians collaborates with national and international partners to ensure the highest standards of research integrity and ethical compliance. By fostering an environment of inquiry and excellence, Rawalpindi Medical College aims to contribute significantly to the field of medicine and the well-being of the community it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rawalpindi, Punjab, Pakistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported